Efeitos do Ato de Fumar na Mortalidade de Longo Prazo após Infarto do Miocárdio por Elevação de ST

Kızıltunç, Emrullah; Şahin, Yusuf; Topal, Salih; Düzenli, Mehmet Akif; Karakaya, Ekrem; Aygül, Nazif; Topsakal, Ramazan; Özdemi̇r, Kurtuluş; Abacı, Adnan

doi:10.36660/abc.20201036

Cited by 1 publication

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, smoking was found to be a strong predictor of all-cause mortality and repeat PCI procedures in these patients. 13 Although the Kızıltunç E et al 14 conducted the study to evaluate the relationship between smoking and death rate pharmaco-invasive strategy, no significant difference in angiographic data and outcomes was found between smokers and non-smokers in all four groups, except for smokers who were treated with pharmaco-invasive strategy, who showed a lower occurrence of TIMI flow III during diagnostic angiography before PCI. 15 Consistently numerous previous studies conducted with thrombolysis have demonstrated that smoking is correlated with lower mortality rates in both short-and long-term follow-up periods.…”

Section: Discussionmentioning

confidence: 96%

In Hospital Outcome Among Smoker and Nonsmoker Patients Presented with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Owais

Ali

Adeel³

et al. 2023

Ann Pak Inst Med Sci

View full text Add to dashboard Cite

Objective: To determine the association between smoking and in-hospital outcomes in patients presented with ST-Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention (PCI). Methodology: This prospective cohort study was conducted at Department of Cardiology, National Institute of Cardiovascular Disease (NICVD), Karachi, from November 9, 2020 to May 8, 2021. All the patients (current smoker, ex-smoker and non-smoker) with age 18 years to 85 years, both gender, patients diagnosed with STEMI in accordance with operational definition and underwent primary PCI were included. Patients diagnosed with ST-Elevation Myocardial Infarction were divided into two groups, expose (smoker) and unexposed (nonsmoker). Before PPCI demographic detail were noted and body mass index was calculated after management of STEMI then PCI was performed. In hospital outcome i.e. heart failure, in-hospital mortality and transient ischemic attack were assessed within 30 days of hospital stay after PCI. All the collected data were entered into the proforma. Results: Mean ±SD of age in exposed group was 56.5±11.8 and non-exposed group was 57.7±12.1 years. In group wise distribution of gender, 82 (70.7%) males and 34 (29.3%) females were enrolled in exposed group and 80 (68.9%) males and 36 (31.1%) females were included in non-exposed group. Risk of heart failure and transient ischemic attack were 1.4 and 5.0 times more likely in exposed as compared to unexposed with [Relative Risk 1.444 and 5.0 respectively. While risk of mortality was 0.2 times less likely in exposed as compared to unexposed with [Relative Risk 0.222] and P value was found to be as significant i.e. (P=0.030). Conclusion: It is to be concluded that significant risk of heart failure and transient ischemic attack were noted in exposed as compared to unexposed and vice versa in case of mortality, but we cannot rule out residual confounders.

show abstract

Section: Discussionmentioning

confidence: 96%